Fidelity Investments’s Entrada Therapeutics TRDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.33M Sell
496,129
-743,682
-60% -$5M ﹤0.01% 2309
2025
Q1
$11.2M Sell
1,239,811
-160,105
-11% -$1.45M ﹤0.01% 1868
2024
Q4
$24.2M Sell
1,399,916
-343,582
-20% -$5.94M ﹤0.01% 1657
2024
Q3
$27.9M Sell
1,743,498
-85,667
-5% -$1.37M ﹤0.01% 1597
2024
Q2
$26.1M Buy
1,829,165
+1,661,244
+989% +$23.7M ﹤0.01% 1554
2024
Q1
$2.38M Sell
167,921
-367,602
-69% -$5.21M ﹤0.01% 2284
2023
Q4
$8.08M Sell
535,523
-46,593
-8% -$703K ﹤0.01% 1924
2023
Q3
$9.2M Buy
582,116
+179
+0% +$2.83K ﹤0.01% 1846
2023
Q2
$8.81M Buy
581,937
+50,529
+10% +$765K ﹤0.01% 1905
2023
Q1
$7.71M Buy
531,408
+27,497
+5% +$399K ﹤0.01% 1969
2022
Q4
$6.81M Buy
503,911
+4
+0% +$54 ﹤0.01% 2030
2022
Q3
$7.94M Sell
503,907
-441,001
-47% -$6.95M ﹤0.01% 1999
2022
Q2
$11.5M Buy
944,908
+68,114
+8% +$830K ﹤0.01% 1905
2022
Q1
$8.23M Buy
876,794
+590,994
+207% +$5.55M ﹤0.01% 2196
2021
Q4
$4.89M Buy
+285,800
New +$4.89M ﹤0.01% 2370